World's Best Scientists 2026 revealed!
Peter T. Lansbury

Peter T. Lansbury

Award Badge
Biology and Biochemistry
Portugal
2023

D-Index & Metrics

Biology and Biochemistry

D-Index
92
Citations
58546
World Ranking
2157
National Ranking
1166

Chemistry

D-Index
81
Citations
46452
World Ranking
3177
National Ranking
1054

Peter T. Lansbury publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Peter T. Lansbury sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 200 publications — 50th percentile

50% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Peter T. Lansbury D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Peter T. Lansbury sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 92 D-Index — 89th percentile

89% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Research.com Recognitions

  • 2023 - Research.com Biology and Biochemistry in Portugal Leader Award
  • 2022 - Research.com Biology and Biochemistry in Portugal Leader Award
  • 1991 - Fellow of Alfred P. Sloan Foundation
  • 1963 - Fellow of Alfred P. Sloan Foundation

Overview

Peter T. Lansbury is affiliated with Harvard University in the United States. Their research primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with a focus on several subfields including Physiology, Neurology, Cell Biology, Molecular Biology, and Cellular and Molecular Neuroscience.

The main topics covered in Lansbury's work include:

  • Lysosomal Storage Disorders Research
  • Parkinson's Disease Mechanisms and Treatments
  • Cellular transport and secretion
  • Neurological disorders and treatments
  • Carbohydrate Chemistry and Synthesis
  • Calcium signaling and nucleotide metabolism
  • Sphingolipid Metabolism and Signaling

Notable recent publications by Lansbury include:

  • "Alpha-synuclein research: defining strategic moves in the battle against Parkinson's disease," 2021, published in npj Parkinson s Disease
  • "A Large-Scale Full GBA1 Gene Screening in Parkinson's Disease in the Netherlands," 2020, published in Movement Disorders
  • "A randomized single and multiple ascending dose study in healthy volunteers of LTI-291, a centrally penetrant glucocerebrosidase activator," 2021, published in British Journal of Clinical Pharmacology
  • "A Phase 1B Trial in GBA1-Associated Parkinson's Disease of BIA-28-6156, a Glucocerebrosidase Activator," 2023, published in Movement Disorders
  • "A Biomarker Study in Patients with GBA1-Parkinson's Disease and Healthy Controls," 2023, published in Movement Disorders

Lansbury frequently collaborates with several co-authors, including Jonas M. den Heijer, Valerie Cullen, Dana Hilt, Geert Jan Groeneveld, and Craig Justman.

Major publication venues for Lansbury's research include:

  • Movement Disorders
  • Journal of Medicinal Chemistry
  • npj Parkinson s Disease
  • British Journal of Clinical Pharmacology
  • Molecular Neurodegeneration

Throughout their career, Lansbury has been recognized as a Fellow of the Alfred P. Sloan Foundation in both 1963 and 1991.

Best Publications

  • Seeding “one-dimensional crystallization” of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie?

    Joseph T. Jarrett;Peter T. Lansbury

  • The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease.

    Joseph T. Jarrett;Elizabeth P. Berger;Peter T. Lansbury

  • Impaired degradation of mutant α-synuclein by chaperone-mediated autophagy

    Ana Maria Cuervo;Leonidas Stefanis;Ross Fredenburg;Peter T. Lansbury

  • Acceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to early-onset Parkinson's disease: Implications for pathogenesis and therapy

    Kelly A. Conway;Seung Jae Lee;Jean Christophe Rochet;Tomas T. Ding

  • Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders.

    Byron Caughey;Peter T. Lansbury

  • MODELS OF AMYLOID SEEDING IN ALZHEIMER'S DISEASE AND SCRAPIE: Mechanistic Truths and Physiological Consequences of the Time-Dependent Solubility of Amyloid Proteins

    James D. Harper;Peter T. Lansbury

  • Neurodegenerative disease: amyloid pores from pathogenic mutations.

    Hilal A. Lashuel;Dean Hartley;Benjamin M. Petre;Thomas Walz

  • NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded.

    Paul H. Weinreb;Weiguo Zhen;Anna W. Poon;Kelly A. Conway

  • Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease.

    Kelly A. Conway;James D. Harper;Peter T. Lansbury

  • Amyloid fibrillogenesis: themes and variations.

    Jean-Christophe Rochet;Peter T Lansbury

  • Kinetic Stabilization of the α-Synuclein Protofibril by a Dopamine-α-Synuclein Adduct

    Kelly A. Conway;Jean-Christophe Rochet;Robert M. Bieganski;Peter T. Lansbury

  • Cell-free formation of protease-resistant prion protein

    David A. Kocisko;David A. Kocisko;Jon H. Come;Jon H. Come;Suzette A. Priola;Bruce Chesebro

  • The UCH-L1 Gene Encodes Two Opposing Enzymatic Activities that Affect α-Synuclein Degradation and Parkinson's Disease Susceptibility

    Yichin Liu;Lara Fallon;Hilal A. Lashuel;Zhihua Liu

  • α-Synuclein, Especially the Parkinson's Disease-associated Mutants, Forms Pore-like Annular and Tubular Protofibrils

    Hilal A. Lashuel;Benjamin M. Petre;Joseph Wall;Martha Simon

  • Amyloid diseases: abnormal protein aggregation in neurodegeneration.

    Edward H. Koo;Peter T. Lansbury;Jeffery W. Kelly

  • Fibrils Formed in Vitro from α-Synuclein and Two Mutant Forms Linked to Parkinson's Disease are Typical Amyloid†

    Kelly A. Conway;James D. Harper;Peter T. Lansbury

  • Observation of metastable Aβ amyloid protofibrils by atomic force microscopy

    James D. Harper;Stanislaus S. Wong;Charles M. Lieber;Peter T. Lansbury

  • Vesicle Permeabilization by Protofibrillar α-Synuclein: Implications for the Pathogenesis and Treatment of Parkinson's Disease†

    Michael J. Volles;Seung-Jae Lee;Jean-Christophe Rochet;Mark D. Shtilerman

  • A century-old debate on protein aggregation and neurodegeneration enters the clinic

    Peter T. Lansbury;Hilal A. Lashuel

  • Evolution of amyloid: What normal protein folding may tell us about fibrillogenesis and disease

    Peter T. Lansbury

Frequent Co-Authors

Hilal A. Lashuel
Hilal A. Lashuel École Polytechnique Fédérale de Lausanne
Byron Caughey
Byron Caughey National Institute of Allergy and Infectious Diseases
E. J. Corey
E. J. Corey Harvard University
Thomas Walz
Thomas Walz Rockefeller University
Paul H. Weinreb
Paul H. Weinreb Biogen (United States)
Bruce Chesebro
Bruce Chesebro National Institutes of Health
Jeffery W. Kelly
Jeffery W. Kelly Scripps Research Institute
Stanislaus S. Wong
Stanislaus S. Wong Stony Brook University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Peter T. Lansbury

Trending Scientists

Recently Published Articles